Searchable abstracts of presentations at key conferences in endocrinology

ea0063p222 | Diabetes, Obesity and Metabolism 1 | ECE2019

Vitamin B12 deficiency prevalence and associated biomarkers in type 2 Diabetes (T2DM) treated with metformin: biochemical assessment in a series of 106 patients

Valdes-Socin Hernan , Vranken Laura , Schoneveld Lauranne , Delannoy Pauline , Goff Caroline Le , Beckers Albert , Cavalier Etienne

Introduction: Increased B12 deficiency among T2DM patients using metformin has been reported. Holotranscobalamin (HoloTc), the bioactive form of B12, is proposed as a specific and sensitive marker of B12 deficiency. Methods to evaluate vitamin B12 deficiency in these patients remain controversial.Methods: First, we studied the prevalence of vitamin B12 deficiency in a group of 106 T2DM patients treated by Metformin, not supplemented by B12. Antacids were...